Stockscreener 앱 받기
0.9689
5.30%
0.0488
시간 외 거래:
1.00
0.0311
+3.21%
전일 마감가:
$0.9201
열려 있는:
$0.96
하루 거래량:
472.05K
Relative Volume:
0.22
시가총액:
$60.83M
수익:
$11.03M
순이익/손실:
$-44.24M
주가수익비율:
-1.5627
EPS:
-0.62
순현금흐름:
$-42.61M
1주 성능:
+21.11%
1개월 성능:
+39.65%
6개월 성능:
+1.09%
1년 성능:
-19.59%
1일 변동 폭
$0.9101
$1.02
1주일 범위
$0.77
$1.09
52주 변동 폭
$0.5327
$1.90
Hyperfine Inc Stock (HYPR) Company Profile
명칭
Hyperfine Inc
전화
866-796-6767
주소
351 NEW WHITFIELD STREET, GUILFORD
HYPR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
0.9689 | 62.27M | 11.03M | -44.24M | -42.61M | -0.62 |
|
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | 개시 | Evercore ISI | Outperform |
| 2022-04-14 | 개시 | Wells Fargo | Overweight |
Hyperfine Inc 주식(HYPR)의 최신 뉴스
What drives Hyperfine Inc. stock priceHigh-yield growth strategies - Autocar Professional
What analysts say about Hyperfine Inc. stockUnprecedented profit potential - Autocar Professional
Is Hyperfine Inc. a good long term investmentDynamic investment growth - jammulinksnews.com
Hyperfine Inc. Stock Analysis and ForecastFree Stock Selection - jammulinksnews.com
What institutions are buying Hyperfine Inc. stock nowRisk Limited High Gain Trades - Newser
Investors Appear Satisfied With Hyperfine, Inc.'s (NASDAQ:HYPR) Prospects As Shares Rocket 47% - 富途牛牛
HYPR Surges 31% on AI-Medical Breakthrough—What’s Next? - AInvest
Hyperfine Announces the First Commercial Sales of the Next-Generation Swoop® System Powered by Optive AI™ Software - 01net
Two hospitals acquire Hyperfine’s next-gen portable MRI systems - Investing.com
Why Hyperfine Inc. stock attracts strong analyst attentionShort Term High Return Strategy - Newser
What makes Hyperfine Inc. stock price move sharplyFree Stock Market Practical Discussion Forums - beatles.ru
How Hyperfine Inc. stock performs during market volatilityReal Time Breakout Tracking - Newser
Hyperfine's Shareholder Dilution: A Recipe for Value Erosion? - AInvest
Wealth Enhancement Advisory Services LLC Sells 25,683 Shares of Hyperfine, Inc. (NASDAQ:HYPR) - Defense World
Hyperfine Welcomes Two New Executives to its Management Team - Medical Product Outsourcing
Hyperfine announces FDA clearance of Swoop system - MSN
Hyperfine (HYPR) Appoints New Chief Regulatory and Quality Officer | HYPR Stock News - GuruFocus
Hyperfine appoints two key executives to strengthen leadership team By Investing.com - Investing.com South Africa
Hyperfine Appoints Rob Fasciano as Chief Regulatory and Rafael O’Halloran as VP of Technology - citybiz
Hyperfine Announces Key Executive Appointments To Strengthen Its Leadership Position In AI-Powered Portable MRI - MarketScreener
Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI - Business Wire
Hyperfine (NASDAQ:HYPR) Trading Down 2.8% – What’s Next? - Defense World
The HYPR Stock Puzzle: Unraveling Hyperfine Inc’s Fluctuating Performance - investchronicle.com
Hyperfine at Jefferies Healthcare: New MRI System Unveiled By Investing.com - Investing.com South Africa
Hyperfine Stock Rises After FDA Clears Next-Gen Swoop MRI System - MSN
Hyperfine at Jefferies Healthcare: New MRI System Unveiled - Investing.com
Hyperfine trading spiked on algorithms caching ‘AI,’ says B. Riley - Yahoo Finance
Hyperfine Wins FDA Nod for Next-Gen Swoop MRI with Optive AI - Medical Product Outsourcing
Hyperfine (HYPR) Sees Surge in Interest Following FDA Approval | HYPR Stock News - GuruFocus
Hyperfine Inc (HYPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
0.17%
자본화:
|
볼륨(24시간):